clavulanic acid has been researched along with cefodizime in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Amicosante, G; Franceschini, N; Oratore, A; Perilli, M; Segatore, B; Setacci, D | 1 |
2 other study(ies) available for clavulanic acid and cefodizime
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Stability; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 1993 |